BRIEF published on 10/31/2024 at 07:03, 21 days 6 hours ago Recticel Experiences Accelerated Growth in Q3 2024 Recticel Market Strategy Net Sales Insulation Boards Q3 2024 Growth
REGULATED PRESS RELEASE published on 10/31/2024 at 06:58, 21 days 6 hours ago Recticel reports accelerated growth in Q3 2024 Recticel reports accelerated growth in Q3 2024 with net sales up 18%. Focus on organic growth and enhanced competitiveness, despite market challenges Recticel Q3 2024 Competitiveness Organic Accelerated Growth
BRIEF published on 08/30/2024 at 07:00, 2 months 22 days ago Recticel Reports H1 Profit Growth in Its First Year as a Building Sustainability Specialist Sustainability Market Strategy EBITDA Increase Profit Growth Insulation Boards
REGULATED PRESS RELEASE published on 08/30/2024 at 06:55, 2 months 22 days ago Recticel reports H1 profit growth as it completes its first year as a building sustainability specialist Recticel reports H1 profit growth of 12.2%, driven by organic growth in Insulation Boards and Insulated Panels amid slow European markets with currency impact Recticel Organic Growth European Markets Insulation Boards H1 Profit Growth
BRIEF published on 06/28/2024 at 18:06, 4 months 22 days ago Capital Increase Through Exercise of Subscription Rights Recticel Capital Increase New Shares Euronext Brussels Subscription Rights
REGULATED PRESS RELEASE published on 06/28/2024 at 18:01, 4 months 22 days ago Capital increase through exercise of subscription rights Recticel increases share capital by 122,500 new ordinary shares through subscription rights. New shares to trade on Euronext Brussels from 2 July 2024 Ordinary Shares Recticel Share Capital Increase Euronext Brussels Subscription Rights
BRIEF published on 05/31/2024 at 18:05, 5 months 20 days ago Recticel Announces Capital Increase Through Subscription Rights Exercise Recticel Capital Increase Euronext Brussels Subscription Rights
REGULATED PRESS RELEASE published on 05/31/2024 at 18:00, 5 months 20 days ago Capital increase through exercise of subscription rights Recticel announces a capital increase through the exercise of subscription rights leading to the issuance of 55,000 new ordinary shares, to be traded on Euronext Brussels Recticel Financial Calendar Capital Increase Euronext Brussels Subscription Rights
BRIEF published on 05/28/2024 at 14:05, 5 months 23 days ago Resolutions of Ordinary General Meeting of Recticel Recticel Dividend Annual Accounts Board Appointments Statutory Auditor
REGULATED PRESS RELEASE published on 05/28/2024 at 14:00, 5 months 23 days ago Resolutions of Ordinary General Meeting Recticel's Ordinary General Meeting approves all proposed resolutions, including dividend distribution of EUR 0.31 per share. Changes in Directors and Statutory Auditor also announced Recticel Dividend Distribution Directors Ordinary General Meeting Statutory Auditor
Published on 11/21/2024 at 13:00, 30 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 30 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 30 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 30 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 30 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 55 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 15 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 32 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 10 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 45 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 45 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
